Back to HomeBeta

ICD-10 Coding for Adenocarcinoma of the Cervix(C53.0, C53.1)

Complete ICD-10-CM coding and documentation guide for Adenocarcinoma of the Cervix. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Cervical AdenocarcinomaEndocervical Adenocarcinoma

Related ICD-10 Code Ranges

Complete code families applicable to Adenocarcinoma of the Cervix

C53Primary Range

Malignant neoplasm of cervix uteri

This range includes all malignant neoplasms of the cervix, including adenocarcinoma.

Carcinoma in situ of cervix uteri

This range is relevant for distinguishing in situ carcinoma from invasive adenocarcinoma.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C53.0Malignant neoplasm of endocervixUse when adenocarcinoma is confirmed to originate from the endocervix.
  • Histologic confirmation of endocervical adenocarcinoma
  • p16 positivity for HPV-associated cases
C53.1Malignant neoplasm of exocervixUse when adenocarcinoma is confirmed to originate from the exocervix.
  • Histologic confirmation of exocervical adenocarcinoma
  • Visible lesion on speculum exam

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for adenocarcinoma cervix

Essential facts and insights about Adenocarcinoma of the Cervix

The ICD-10 code for adenocarcinoma of the cervix is C53.0 for endocervical origin and C53.1 for exocervical origin.

Primary ICD-10-CM Codes for adenocarcinoma cervix

Malignant neoplasm of endocervix
Billable Code

Decision Criteria

clinical Criteria

  • Histologic confirmation of adenocarcinoma in the endocervix

documentation Criteria

  • Documented HPV status and tumor size

Applicable To

  • Adenocarcinoma arising from endocervical glands

Excludes

  • Carcinoma in situ of endocervix (D06.0)

Clinical Validation Requirements

  • Histologic confirmation of endocervical adenocarcinoma
  • p16 positivity for HPV-associated cases

Code-Specific Risks

  • Incorrectly coding as unspecified when histology is known

Coding Notes

  • Ensure documentation specifies the site within the cervix and HPV status.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of malignant neoplasm of cervix uteri

Z85.43
Use for patients with a history of cervical cancer.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Carcinoma in situ of endocervix

D06.0
Use D06.0 for non-invasive carcinoma confined to the endocervical epithelium.

Carcinoma in situ of exocervix

D06.1
Use D06.1 for non-invasive carcinoma confined to the exocervical epithelium.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Adenocarcinoma of the Cervix to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C53.0.

Impact

Clinical: Inadequate information for treatment planning, Regulatory: Non-compliance with documentation standards, Financial: Potential for denied claims due to insufficient documentation

Mitigation Strategy

Use structured templates for documentation, Ensure all pathology reports include tumor metrics

Impact

Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.

Mitigation Strategy

Always specify the histologic subtype and HPV status when available.

Impact

Failure to document HPV status can lead to incorrect coding.

Mitigation Strategy

Implement mandatory fields for HPV status in electronic health records.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Adenocarcinoma of the Cervix, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Adenocarcinoma of the Cervix

Use these documentation templates to ensure complete and accurate documentation for Adenocarcinoma of the Cervix. These templates include all required elements for proper coding and billing.

Gynecologic Oncology Op Note

Specialty: Gynecologic Oncology

Required Elements

  • Tumor size
  • Depth of invasion
  • HPV status
  • Lymphovascular space invasion (LVSI)

Example Documentation

Robotic radical hysterectomy performed for 3.1cm endocervical adenocarcinoma (p16+, HPV 18+). Tumor invades 12mm through 18mm cervical wall. Parametria free. 32 lymph nodes removed (0/32 positive). Final staging: FIGO IB3 pT1b3 pN0.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Adenocarcinoma of cervix.
Good Documentation Example
HPV-associated usual-type adenocarcinoma measuring 2.3 cm invading 8mm into cervical stroma. p16 diffusely positive. LVSI present. Margins clear at 5mm. FIGO IB2.
Explanation
The good example includes specific details about HPV status, tumor size, invasion depth, and staging, which are crucial for accurate coding and treatment planning.

Need help with ICD-10 coding for Adenocarcinoma of the Cervix? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more